Sequenom to Acquire Axiom Biotechnologies; Plans Spree of New Releases | GenomeWeb

NEW YORK, Aug. 21 - Sequenom has 18 busy months ahead of it.

The company today announced plans to acquire privately held Axiom Biotechnologies, which Sequenom said will help its nascent pharma division build some internal biology, assay, and drug-discovery muscle. Sequenom also said it will release a gaggle of new products and updated technology beginning in the third quarter and continuing into 2004.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.